A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Pfizer
Incyte Corporation
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Mayo Clinic
Alliance for Clinical Trials in Oncology
Baylor College of Medicine
Vanderbilt-Ingram Cancer Center
Mayo Clinic